Brown Brothers Harriman & Co’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-4,300
Closed -$1.23M 1321
2023
Q2
$1.23M Hold
4,300
0.01% 219
2023
Q1
$932K Hold
4,300
0.01% 254
2022
Q4
$884K Hold
4,300
0.01% 243
2022
Q3
$1.2M Sell
4,300
-1,000
-19% -$254K 0.01% 198
2022
Q2
$1.01M Hold
5,300
0.01% 216
2022
Q1
$1.1M Hold
5,300
0.01% 236
2021
Q4
$945 Buy
+5,300
New +$1.05M 0.01% 250

Other funds holding SWAV

Brown Brothers Harriman & Co's SWAV Position: Q3 2023 in Review

Brown Brothers Harriman & Co sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q3 2023, closing a stake of 4,300 shares — an estimated $1.23M sold.

Brown Brothers Harriman & Co first reported a position in SWAV in Q4 2021 and held it in 7 quarters. The position peaked at $1.23M in Q2 2023. 412 funds tracked by Wall St. Rank hold SWAV as of Q3 2023.

  • Brown Brothers Harriman & Co reported no remaining Shockwave Medical, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Brown Brothers Harriman & Co sold 4,300 Shockwave Medical, Inc. Common Stock shares in Q3 2023, an estimated $1.23M.
  • Brown Brothers Harriman & Co first reported a position in Shockwave Medical, Inc. Common Stock in Q4 2021 and held it in 7 quarters.
  • Brown Brothers Harriman & Co's Shockwave Medical, Inc. Common Stock position peaked at $1.23M in Q2 2023.
  • 412 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q3 2023.

Based on Brown Brothers Harriman & Co's 13F filing for Q3 2023, filed 13 Nov 2023.